About
Team
Pipeline
OPN-2853
OPN-6602
OPN-FMRP
OPN-7486
OPN-9840
OPN-9627
Patients
News
Press Releases
Publications
& Posters
Careers
Contact
General information
info@opnabio.com
Investor inquiries
bd@opnabio.com
Media and BD inquiries
bd@opnabio.com
OPN-TEAD
Select PROGRAMS
All Programs
OPN-2853
(9)
OPN-51107
(17)
OPN-6602
(3)
OPN-7486
(5)
OPN-TEAD
(1)
Select Dates
All Dates
2024
(4)
2023
(3)
2022
(1)
2021
(3)
2020
(3)
2019
(7)
2018
(4)
2017
(3)
2016
(2)
2015
(3)
April 10, 2024
Poster
OPN-9840, a non-covalent potent pan-TEAD inhibitor, exhibits single agent efficacy in preclinical malignant mesothelioma models
AUTHORS
Chen, et al
Programs
OPN-TEAD
Download PDF